The billionaire is working with the W.H.O., drugmakers and
nonprofits to defeat the coronavirus everywhere, including in the world's
poorest nations. Can they do it?
The head of one of
the world’s largest vaccine manufacturers had a problem. Adar Poonawalla, chief
executive of the Serum
Institute of India, needed $850 million for everything from glass vials to
stainless steel vats so he could begin producing doses of promising coronavirus
vaccines for the world’s poor.
Mr. Poonawalla
calculated that he could risk $300 million of his company’s money but would
still be more than a half-billion dollars short. So he looked to a retired
software executive in Seattle.
Bill
Gates, the Microsoft founder turned philanthropist, had known Mr.
Poonawalla for years. Mr. Gates had spent billions to help bring vaccines to
the developing world, working closely with pharmaceutical executives to
transform the market. In doing so, he became the most powerful — and provocative
— private player in global health.
By the end of
their conversation this summer, Mr. Gates had made a promise: The Bill and
Melinda Gates Foundation would provide a $150 million guarantee so the Indian
factory could move ahead with production. By September, the foundation had
doubled its commitment.
It is part of an
$11 billion effort to lay the groundwork to procure coronavirus vaccines for
more than 150 countries, though it could eventually cost far more when the
doses come through. Funded largely with public money, the initiative is led by
two global nonprofits that Mr. Gates helped launch and bankroll, along with the
World Health Organization, which relies on the Gates Foundation as one of its
largest donors.
Working behind the
scenes is the world’s second-richest man, neither a scientist nor a doctor, who
sees himself and his $50 billion foundation as uniquely prepared to take a
central part. Mr. Gates and his team are drawing on connections and
infrastructure the foundation has built over two decades to help guide the
effort.
No comments:
Post a Comment